• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Novo diabetes drug cuts heart risks by less-than-hoped 13 percentage
(Reuters) - Novo Nordisk's top-selling diabetes drug Victoza cut the risk of heart attack, stroke and cardiovascular death by 13 percent in a closely watched study, but the result disappointed investors who had hoped for more.
Source: Reuters: Health - June 14, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Novo diabetes drug cuts heart risks by 13 percent in key trial
(Reuters) - Novo Nordisk's top-selling diabetes drug Victoza cut the risk of heart attack, stroke and cardiovascular death by 13 percent in a closely watched study that may help boost sales of the injectable medicine.
Source: Reuters: Health - June 13, 2016 Category: Consumer Health News Tags: healthNews Source Type: news